184 related articles for article (PubMed ID: 38022610)
1. Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders.
Dudler T; Yaseen S; Cummings WJ
Front Immunol; 2023; 14():1297352. PubMed ID: 38022610
[TBL] [Abstract][Full Text] [Related]
2. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
Rambaldi A; Gritti G; Micò MC; Frigeni M; Borleri G; Salvi A; Landi F; Pavoni C; Sonzogni A; Gianatti A; Binda F; Fagiuoli S; Di Marco F; Lorini L; Remuzzi G; Whitaker S; Demopulos G
Immunobiology; 2020 Nov; 225(6):152001. PubMed ID: 32943233
[TBL] [Abstract][Full Text] [Related]
3. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2.
Cseh S; Vera L; Matsushita M; Fujita T; Arlaud GJ; Thielens NM
J Immunol; 2002 Nov; 169(10):5735-43. PubMed ID: 12421953
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
Kocsis A; Kékesi KA; Szász R; Végh BM; Balczer J; Dobó J; Závodszky P; Gál P; Pál G
J Immunol; 2010 Oct; 185(7):4169-78. PubMed ID: 20817870
[TBL] [Abstract][Full Text] [Related]
6. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL.
Thielens NM; Cseh S; Thiel S; Vorup-Jensen T; Rossi V; Jensenius JC; Arlaud GJ
J Immunol; 2001 Apr; 166(8):5068-77. PubMed ID: 11290788
[TBL] [Abstract][Full Text] [Related]
7. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
[TBL] [Abstract][Full Text] [Related]
8. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway.
Megyeri M; Harmat V; Major B; Végh Á; Balczer J; Héja D; Szilágyi K; Datz D; Pál G; Závodszky P; Gál P; Dobó J
J Biol Chem; 2013 Mar; 288(13):8922-34. PubMed ID: 23386610
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activities of two types of mannose-binding lectin-associated serine protease.
Matsushita M; Thiel S; Jensenius JC; Terai I; Fujita T
J Immunol; 2000 Sep; 165(5):2637-42. PubMed ID: 10946292
[TBL] [Abstract][Full Text] [Related]
10. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides.
Talsma DT; Poppelaars F; Dam W; Meter-Arkema AH; Vivès RR; Gál P; Boons GJ; Chopra P; Naggi A; Seelen MA; Berger SP; Daha MR; Stegeman CA; van den Born J;
Front Immunol; 2020; 11():732. PubMed ID: 32425936
[TBL] [Abstract][Full Text] [Related]
11. Distinction of early complement classical and lectin pathway activation
Hurler L; Toonen EJM; Kajdácsi E; van Bree B; Brandwijk RJMGE; de Bruin W; Lyons PA; Bergamaschi L; ; Sinkovits G; Cervenak L; Würzner R; Prohászka Z
Front Immunol; 2022; 13():1039765. PubMed ID: 36420270
[TBL] [Abstract][Full Text] [Related]
12. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
[TBL] [Abstract][Full Text] [Related]
13. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.
Takahashi M; Ishida Y; Iwaki D; Kanno K; Suzuki T; Endo Y; Homma Y; Fujita T
J Exp Med; 2010 Jan; 207(1):29-37. PubMed ID: 20038603
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2.
Zundel S; Cseh S; Lacroix M; Dahl MR; Matsushita M; Andrieu JP; Schwaeble WJ; Jensenius JC; Fujita T; Arlaud GJ; Thielens NM
J Immunol; 2004 Apr; 172(7):4342-50. PubMed ID: 15034049
[TBL] [Abstract][Full Text] [Related]
15. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled SK; Claes K; Goh YT; Kwong YL; Leung N; Mendrek W; Nakamura R; Sathar J; Ng E; Nangia N; Whitaker S; Rambaldi A;
J Clin Oncol; 2022 Aug; 40(22):2447-2457. PubMed ID: 35439028
[TBL] [Abstract][Full Text] [Related]
16. Narsoplimab for severe transplant-associated thrombotic microangiopathy.
Pandrowala A; Ganatra P; Krishnan VP; Sharma AN; Chavan S; Bodhanwala M; Agarwal B; Hiwarkar P
Thromb J; 2023 Mar; 21(1):26. PubMed ID: 36915123
[TBL] [Abstract][Full Text] [Related]
17. Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.
Nagy ZA; Héja D; Bencze D; Kiss B; Boros E; Szakács D; Fodor K; Wilmanns M; Kocsis A; Dobó J; Gál P; Harmat V; Pál G
J Biol Chem; 2022 Jun; 298(6):101985. PubMed ID: 35483450
[TBL] [Abstract][Full Text] [Related]
18. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes.
Schwaeble W; Dahl MR; Thiel S; Stover C; Jensenius JC
Immunobiology; 2002 Sep; 205(4-5):455-66. PubMed ID: 12396007
[TBL] [Abstract][Full Text] [Related]
19. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.
Ambrus G; Gál P; Kojima M; Szilágyi K; Balczer J; Antal J; Gráf L; Laich A; Moffatt BE; Schwaeble W; Sim RB; Závodszky P
J Immunol; 2003 Feb; 170(3):1374-82. PubMed ID: 12538697
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.
Rossi V; Teillet F; Thielens NM; Bally I; Arlaud GJ
J Biol Chem; 2005 Dec; 280(51):41811-8. PubMed ID: 16227207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
